Analysis of the range of metformin hydrochloride medicines for the treatment of type II diabetes mellitus
DOI:
https://doi.org/10.24959/sphhcj.22.251Keywords:
market analysis; type II diabetes mellitus; metformin hydrochloride; assortmentAbstract
Aim. To analyze the range of metformin hydrochloride medicines registered at the pharmaceutical market of Ukraine for the treatment of type II diabetes mellitus.
Materials and methods. When conducting the analysis the data of the State Register of Medicines of Ukraine, namely, reference resources, in particular the Compendium drug reference book, unified clinical protocols for the treatment of type II diabetes in adults, were used as research materials. In the course of the study, documentary, analytical, mathematical-statistical and logical data generalization methods were used. Graphical and tabular methods with explanations and conclusions were used to visually present the research results. The analysis of the structure of the assortment of metformin hydrochloride medicines was
carried out taking into account trade names of the drugs, countries producing these drugs, dosage forms and the composition of the drugs.
Results. According to the results of the study, the ratio of metformin hydrochloride medicines of domestic and foreign production has been found. It has been determined that 65 % of the total range consists of foreign-made drugs, mainly from India (37 %) and France (15 %). When studying the structure of the assortment of metformin hydrochloride medicines of domestic production, 6 manufacturers have been identified; among them 40 % of the domestic assortment is manufactured by Farmak JSC. In addition, the list of metformin hydrochloride medicines made by domestic manufacturers from in bulk tablets of foreign (mainly Indian) production has been detailed. It has been found that all metformin hydrochloride medicines
are available in the form of solid dosage forms, mainly in the form of coated tablets (75 % of the total amount of drugs), in three doses.
Conclusions. Based on the analysis, it has been found that more than 160 metformin hydrochloride medicines are registered in Ukraine; the vast majority of them are of foreign production. It has been determined that most domestic manufacturers produce metformin hydrochloride medicines from foreign-made tablets in bulk.
Key words: market analysis; type II diabetes mellitus; metformin hydrochloride; assortment.
References
Kompendium. Lekarstvennye preparaty. Available at: http://compendium.com.ua.
MOZ Ukrainy. (2012). Nakaz vid 12.12.2012 roku No. 1118 “Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry tsukrovomu diabeti 2 typu”. zakon.rada.gov.ua. Available at: https://zakon.rada.gov.ua/rada/show/v1118282-12#Text.
Hurieva, I. V. (2007). Sakharnyi diabet, 10 (4), 54-56. doi: https://doi.org/10.14341/2072-0351-5868.
European Society of Cardiology and European Association for the Study of Diabetes Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases. Available at: https://academic.oup.com/eurheartj/article/41/2/255/5556890.
The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: National clinical guideline for management in primary and secondary care (updated 2008). Available at: https://www.ncbi.nlm.nih.gov/books/NBK53885/.
The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes. Available at: https://www.ncbi.nlm.nih.gov/books/NBK61842/.
Melnikova, O. H. (2008). Sakharnyi diabet, 11 (4), С. 91-92. doi: https://doi.org/10.14341/2072-0351-5599.
Nemchenko, A. S., Zhyrova, I. V. (2013). Upravlinnia ta ekonomika u farmatsii, 1 (33), 59-62.
Savych, A. O., Pavlenko, B. V. (2022). Aktualni pytannia farmatsevtychnoi ta medychnoi nauky ta praktyky, 15 (1), 80-86. doi: https://doi.org/10.14739/2409-2932.2022.1.252509.
Derzhavnyi reiestr likarskych zasobiv. Available at: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument&sklad=%EC%E5%F2%F4%EE%F0%EC%B3%ED.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).